Levin Capital Strategies, L.P. Aura Biosciences, Inc. Transaction History
Levin Capital Strategies, L.P.
- $1.03 Billion
- Q3 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 413,635 shares of AURA stock, worth $3.62 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
413,635
Previous 327,466
26.31%
Holding current value
$3.62 Million
Previous $2.48 Million
48.89%
% of portfolio
0.36%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$60.6 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$50.8 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$42.7 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$26.6 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$26.3 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $256M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...